These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27913395)

  • 21. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
    Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
    BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis.
    Xiao J; Zhao Y; Varghese RS; Zhou B; Di Poto C; Zhang L; Tadesse MG; Ziada DH; Shetty K; Ressom HW
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):64-72. PubMed ID: 24186894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma.
    Omran MM; Farid K; Omar MA; Emran TM; El-Taweel FM; Tabll AA
    Ann Hepatol; 2020; 19(2):179-185. PubMed ID: 31648804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.
    Wang M; Devarajan K; Singal AG; Marrero JA; Dai J; Feng Z; Rinaudo JA; Srivastava S; Evans A; Hann HW; Lai Y; Yang H; Block TM; Mehta A
    Cancer Prev Res (Phila); 2016 Feb; 9(2):172-9. PubMed ID: 26712941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
    Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
    Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma nuclear factor kappa B and serum peroxiredoxin 3 in early diagnosis of hepatocellular carcinoma.
    Ismail S; Mayah W; Battia HE; Gaballah H; Jiman-Fatani A; Hamouda H; Afifi MA; Elmashad N; Saadany SE
    Asian Pac J Cancer Prev; 2015; 16(4):1657-63. PubMed ID: 25743848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
    Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
    Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
    BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
    Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
    Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
    Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
    Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
    PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
    Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
    Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
    Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S; Khan AA; Tarique S
    J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of serum endoglin level in Egyptian hepatocellular carcinoma patients.
    Elnemr DM; Abdel-Azeez HA; Labib HA; Abo-Taleb FM
    Clin Lab; 2012; 58(9-10):1023-8. PubMed ID: 23163119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients.
    Gani RA; Suryamin M; Hasan I; Lesmana CR; Sanityoso A
    Acta Med Indones; 2015 Jul; 47(3):216-22. PubMed ID: 26586387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.